2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Polycystic Ovary Syndrome
18
Carcinoma, Non-Small-Cell Lung
14
Colorectal Neoplasms
11
Lung Neoplasms
9
Recurrence
7
Neoplasm Metastasis
5
Colonic Neoplasms
5
Breast Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Infertility
4
Neoplasms
3
Lymphoma, T-Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Papillomavirus Infections
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Insulin Resistance
2
Infertility, Female
2
Hyperandrogenism
2
Head and Neck Neoplasms
2
Diabetes, Gestational
2
Carcinoma, Transitional Cell
2
Atypical Squamous Cells of the Cervix
2
Interventions
Gemcitabine
13
pembrolizumab
9
Specimen Handling
9
enfortumab vedotin
8
Cisplatin
8
Magnetic Resonance Spectroscopy
7
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
eribulin
2
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Radiotherapy
2
Platinum
2
Nephroureterectomy
2
Ipilimumab
2
Doxorubicin
2
Docetaxel
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tremelimumab
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Folic Acid
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled